Cargando…
Risk factors for early recurrence in patients with pancreatic ductal adenocarcinoma who underwent curative resection
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers, and surgical resection is the only potentially curative approach. However, the rate of recurrence remains high, particularly within the first 6 months, and is associated with a poor prognosis. The present study ev...
Autores principales: | Murakawa, Masaaki, Kawahara, Shinnosuke, Takahashi, Daishi, Kamioka, Yuto, Yamamoto, Naoto, Kobayashi, Satoshi, Ueno, Makoto, Morimoto, Manabu, Sawazaki, Sho, Tamagawa, Hiroshi, Ohshima, Takashi, Yukawa, Norio, Rino, Yasushi, Morinaga, Soichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463749/ https://www.ncbi.nlm.nih.gov/pubmed/37620940 http://dx.doi.org/10.1186/s12957-023-03141-3 |
Ejemplares similares
-
The impact of SPARC expression on the survival of pancreatic ductal adenocarcinoma patients after curative resection
por: Murakawa, Masaaki, et al.
Publicado: (2019) -
Clinical implications of ribonucleotide reductase subunit M1 in patients with pancreatic cancer who undergo curative resection followed by adjuvant chemotherapy with gemcitabine
por: Aoyama, Toru, et al.
Publicado: (2017) -
Predictive role of human equilibrative nucleoside transporter 1 in patients with pancreatic cancer treated by curative resection and gemcitabine-only adjuvant chemotherapy
por: Aoyama, Toru, et al.
Publicado: (2017) -
Rapidly progressed neuroendocrine carcinoma in the extrahepatic bile duct: a case report and review of the literature
por: Kamiya, Mariko, et al.
Publicado: (2020) -
Primary Duodenal Carcinoma with Embryonal Carcinoma Features in a Young Man
por: Yamamoto, Naoto, et al.
Publicado: (2021)